Standigm names Carl Foster as Chief Business Officer
Korea | News | 0 Comment | 19 Aug, 2022
South Korea-based startup Standigm Inc. has announced the appointment of Chief Business Officer Carl Foster. Based ...Read more
Korea deploys AI & 3D bioprinting for diabetes foot and osteoarthritis treatment
Korea | News | 1 Comment | 16 Aug, 2022
South Korea-based ROKIT Healthcare will provide a hyper-personalized medical platform that uses 3D bioprinting and artif...Read more
South Korea approves Nuvaxovid COVID-19 vaccine for use in adolescents
Korea | News | 0 Comment | 14 Aug, 2022
US-based Novavax, Inc. has announced that partner, SK bioscience, has received a Post Approval Change Application approv...Read more
Panacell Biotech begins hunt for long COVID treatment
Korea | News | 0 Comment | 11 Aug, 2022
According to South Korea-based Panacell Biotech, NK cells, exosomes, and brown adipose-derived stem cells are effective ...Read more
Korean firm develops new CRISPR/Cas technology specific for bacteriophage
Korea | News | 0 Comment | 10 Aug, 2022
iNtRON Biotechnology has developed its unique CRISPR/Cas system customized for the genetic modification of certain bacte...Read more
Korea develops new therapeutic drug for Alzheimer’s disease
Korea | News | 0 Comment | 09 Aug, 2022
Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA app...Read more
South Korean startup Vuno receives MFDS certification for electrocardiogram device
Korea | News | 0 Comment | 03 Aug, 2022
South Korea based VUNO, a global medical artificial intelligence solution company, has obtained the Ministry of Food and...Read more
Korea's GenKOre develops new base-editing technology for treating genetic diseases
Korea | News | 0 Comment | 02 Aug, 2022
GenKOre, a biotech startup in South Korea, succeeded in the development of adenine base editors (ABEs) based on its own ...Read more
SK bioscience seeks European approval for COVID-19 vaccine
Korea | News | 0 Comment | 03 Aug, 2022
South Korea-based SK bioscience, a global innovative vaccine and biotech company dedicated to promoting human health fro...Read more
South Korea-based ilooda's device wins US FDA approval for treating scars post
Korea | News | 0 Comment | 28 Jul, 2022
Secret Duo of South Korea's ilooda Co., Ltd., which develops, manufactures and sells specialized medical devices to...Read more
World-class Foot and Mouth Disease vaccine site to come up in South Korea
Korea | News | 0 Comment | 26 Jul, 2022
Argentina-based Biogénesis Bagó, an international biotechnology company focused on animal health and globa...Read more
Baxter launches new diabetic retinopathy screening device in South Korea
Korea | News | 0 Comment | 25 Jul, 2022
US-based firm Baxter has launched Welch Allyn RetinaVue 100 Imager PRO in South Korea, that enables diabetic retino...Read more
Korea's IVI inks MoU with Moderna for vaccine R&D
Korea | News | 0 Comment | 21 Jul, 2022
South Korea-based International Vaccine Institute (IVI) and US-based Moderna have signed a Memorandum of Understanding (...Read more
SK bioscience to manufacture Novavax' COVID-19 vaccine against omicron
Korea | News | 0 Comment | 22 Jul, 2022
South Korea's SK bioscience has extended its partnership with Novavax, a US-based biotechnology company specializing in ...Read more
Samsung Biologics further invests KRW 426 B for Bio Campus 2
Korea | News | 0 Comment | 18 Jul, 2022
Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...Read more
Eurofarma to sell SK Biopharmaceuticals' epilepsy drug in Latin America
Korea | News | 0 Comment | 15 Jul, 2022
South Korea's SK Biopharmaceuticals has entered into a licensing agreement for Eurofarma, a Brazilian pharmaceutical com...Read more
GenScript ProBio partners with DAAN Bio Therapeutics for novel drug discovery
Korea | News | 0 Comment | 14 Jul, 2022
GenScript ProBio, a global CDMO, and South Korea-based startup DAAN Bio Therapeutics, have entered into a strategic...Read more
GenScript ProBio signs MoU with ACT Therapeutics to develop new CAR-T cell therapies
Korea | News | 0 Comment | 13 Jul, 2022
GenScript ProBio, a global CDMO, and South Korea-based ACT Therapeutics have entered into a strategic partnership M...Read more